American Association of Diabetes Educators

Jennifer Clements, PharmD, BCPS, CDE

Program Objective: Demonstrate how to enhance the role of the diabetes educator in a time of innovative change

Learning Objective: Explain the pharmacological mechanisms of emerging therapies for diabetes mellitus. Summarize clinical trial data examining the efficacy and safety of emerging therapy for the management of diabetes mellitus. Identify individuals with diabetes mellitus who may benefit from emerging therapies.

There are several available options for the management of diabetes mellitus. However, there remain unmet needs to the management of this chronic disease. Emerging therapies have been designed to provide alternative options, but not resolve the unmet needs. Currently, there is evidence of incretns (exedin-4 backbone and human GLP-1 backbone agents), sodium glucose co-transporter inhibitors, and ultra-long acting insulins. These agents have advantages and disadvantages to current treatment, but may have a promising role in the management of diabetes mellitus.